Expertise in
13
conditions

Dr. Janet G. Turner

Gynecologic Oncology | Oncology | Obstetrics and Gynecology
Upper Great Lakes Family Health Center
500 Campus Dr, 
Hancock, MI 
Accepting New Patients
Expertise in
13
conditions
Upper Great Lakes Family Health Center
500 Campus Dr, 
Hancock, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Janet Turner is a Gynecologic Oncologist and an Oncologist in Hancock, Michigan. Dr. Turner is highly rated in 13 conditions, according to our data. Her top areas of expertise are Endometrial Stromal Sarcoma, Endometrial Cancer, Malignant Mixed Mullerian Tumor, Vulvar Cancer, and Hysterectomy. Dr. Turner is currently accepting new patients.

Her clinical research consists of participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Florida College Of Medicine
Specialties
Gynecologic Oncology
Oncology
Obstetrics and Gynecology
Licenses
Obstetrics & Gynecology in TN
Hospital Affiliations
Up Health System Portage
Waukesha Memorial Hospital
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Children's Community Health
  • EPO
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Dean Health
  • EPO
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Network Health
  • HMO
Quartz
  • HMO
  • POS
  • PPO
Quartz Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Upper Peninsula Health Plan
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

UPPER GREAT LAKES FAMILY HEALTH CENTER
500 Campus Dr, Hancock, MI 49930

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
A Phase III Study Comparing Single-Agent Olaparib or the Combination of Cediranib and Olaparib to Standard Platinum-Based Chemotherapy in Women With Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Drug, Procedure, Other
Study Drugs: Carboplatin, Cediranib Maleate, Gemcitabine, Gemcitabine Hydrochloride, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride
Study Phase: Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: September 22, 2025
Intervention Type: Other, Radiation, Drug
Study Drug: Temozolomide
Study Phase: Phase 2
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
A Randomized Phase II/III Study of the Combination of Cediranib and Olaparib Compared to Cediranib or Olaparib Alone, or Standard of Care Chemotherapy in Women With Recurrent Platinum-Resistant or -Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer (COCOS)
Enrollment Status: Active_not_recruiting
Publish Date: September 16, 2025
Intervention Type: Procedure, Drug, Other
Study Drugs: Cediranib, Cediranib Maleate, Olaparib, Paclitaxel, Pegylated Liposomal Doxorubicin Hydrochloride, Topotecan, Topotecan Hydrochloride
Study Phase: Phase 2/Phase 3
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Evaluation of Physical Function and Quality of Life (QOL) Before and After Non-Radical Surgical Therapy (Extra Fascial Hysterectomy or Cone Biopsy With Pelvic Lymphadenectomy) for Stage IA1 (LVSI+) and IA2-IB1 (≤ 2CM) Cervical Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 03, 2024
Intervention Type: Other, Procedure
Study Phase: Not Applicable
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
A Randomized Phase II/III Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IVA, Stage IVB, or Recurrent Endometrial Cancer
Enrollment Status: Unknown
Publish Date: September 30, 2021
Intervention Type: Other, Drug
Study Drugs: Carboplatin, Metformin hydrochloride, Paclitaxel
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
0
conditions
Dr. Evon L. Schexnaydre
Obstetrics and Gynecology
Expertise in
0
conditions
Dr. Evon L. Schexnaydre
Obstetrics and Gynecology

Upper Great Lakes Family Health Center

500 Campus Dr, 
Hancock, MI 
 (0.1 miles away)
906-483-1060
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Evon Schexnaydre is an Obstetrics and Gynecologist in Hancock, Michigan. Her top areas of expertise are Vaginal Cysts, Vaginal Dryness, Neuralgia, Rectocele, and Hormone Replacement Therapy (HRT). Dr. Schexnaydre is currently accepting new patients.

Expertise in
1
conditions
Dr. Bonnie L. Hafeman
Family Medicine | Palliative Medicine | Obstetrics and Gynecology
Expertise in
1
conditions
Dr. Bonnie L. Hafeman
Family Medicine | Palliative Medicine | Obstetrics and Gynecology

Aspirus Keweenaw

205 Osceola St, 
Laurium, MI 
 (9.5 miles away)
906-337-3100
Languages Spoken:
English, German
See accepted insurances
Accepting New Patients

Bonnie Hafeman is a Palliative Medicine specialist and an Obstetrics and Gynecologist in Laurium, Michigan. Dr. Hafeman is highly rated in 1 condition, according to our data. Her top areas of expertise are Thrush, Familial Chronic Mucocutaneous Candidiasis, Vitamin B12 Deficiency, Hernia Surgery, and Endoscopy. Dr. Hafeman is currently accepting new patients.

Expertise in
0
conditions
Dr. Steven H. Woodworth
Reproductive Medicine | Endocrinology | Obstetrics and Gynecology
Expertise in
0
conditions
Dr. Steven H. Woodworth
Reproductive Medicine | Endocrinology | Obstetrics and Gynecology

Aspirus Keweenaw

205 Osceola St, 
Laurium, MI 
 (9.5 miles away)
906-337-3100
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Steven Woodworth is a Reproductive Medicine specialist and an Endocrinologist in Laurium, Michigan. His top areas of expertise are Hypothyroidism, Hypopituitarism, Growth Hormone Deficiency (GHD), and Isolated Hypogonadotropic Hypogonadism. Dr. Woodworth is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Turner's expertise for a condition
ConditionClose
    View All 10 Advanced Conditions
    View All 19 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile